2.0-header-iStock-927097162

¿Qué es la osteoartritis?

Osteoarthritis is a chronic (long-lasting) disease, the most common form of arthritis.14

Osteoarthritis is a degenerative or “wear-and-tear” condition 16 that occurs in all the joint tissues (cartilage, bone, muscles and ligaments) of an affected joint. Osteoarthritis commonly affects knees, hands, and hips.14

There is no cure for osteoarthritis, but there are treatment options available to help reduce pain, improve function, and in some cases, delay disease progression.14

Stages of Knee Osteoarthritis

Interior de una articulación con osteoartritis

  1. Cartílago normal: proporciona una superficie lisa que permite a los huesos moverse con facilidad.
  2. Líquido sinovial: lubrica y absorbe los impactos durante la actividad porque contiene una elevada concentración de ácido hialurónico.
  3. Hueso normal: proporciona fuerza y apoyo a los tejidos y órganos del cuerpo.
  4. Cartílago erosionado: si está totalmente desgastado, los huesos pueden rozar entre sí, produciendo dolor.
  5. Líquido sinovial osteoartrítico: la degeneración por osteoartritis causa una producción inferior de ácido hialurónico y disminuye la calidad funcional.
  6. Hueso osteoartrítico: contiene osteofitos, que también se denominan crecimientos de espolones óseos.

Más información sobre las causas, síntomas y diagnóstico de la osteoartritis..

Summary of Indications for Use

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.